Stay updated on Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page has removed two significant studies related to the efficacy and safety of Nivolumab in treating metastatic esophagogastric cancer and recurrent metastatic urothelial carcinoma, which may impact the information available to readers about these treatments.
    Difference
    0.7%
    Check dated 2025-05-08T05:28:20.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T03:20:09.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version of the clinical trial study, with the previous version's details about tumor types and enrollment status removed. The new version includes a focus on advanced or metastatic solid tumors and updates the revision number.
    Difference
    11%
    Check dated 2025-04-16T14:24:30.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to December 27, 2024.
    Difference
    0.6%
    Check dated 2025-04-09T09:13:10.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:17:39.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:44:11.000Z thumbnail image

Stay in the know with updates to Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page.